Allergic rhinitis (AR) is defined as chronic inflammatory reactions to common allergens in the nasal mucosa with at least two AR symptoms including rhinorrhea, nasal congestion, sneezing, nasal/ocular pruritus, and postnasal drainage. AR is a common health problem, and it affects around 10-25% of general population. Its prevalence is increasing according to the environmental changes. AR and asthma frequently coexist in the same patient, therefore we should consider it and check for asthma to diagnose AR. Antihistamines and nasal corticosteroids are recommended as the 1st line treatment of AR. Decongestants may be effective for nasal congestion, and leukotrienes are helpful to improve both nasal and bronchial inflammations in patients with AR and asthma. Allergen specific immunotherapy is useful in IgE mediated AR and can prevent the progression to asthma and new sensitizations. Appropriate AR treatment including medications and immunotherapy can improve symptoms and reduce medications. Finally improvement of quality of life can be achieved. (Korean J Med 2013;85:463-468) 
Advantages of intranasal administration
High concentrations can be delivered directly into the target organ avoiding or minimizing systemic effects.
Some of the drugs (eg. Cromones) should be administered only via the intranasal routes as they are not adequately absorbed when given orally.
Some drugs have systemic effects when administered orally (e.g. intranasal glucocorticosteroids are also effective in allergic conjunctivitis) [11] .
The onset of action is faster than that of an oral drug.
Problems of intranasal administration
Some patients experience side effects of crusting and bleeding.
Some local side effects may be occurred. (e.g. rhinitis medicamentosa, nasal dryness, nasal bleeding and so on.)
Intranasal medication cannot be given when the nose is completely blocked.
Especially if multiple target organs should be treated, oral drugs may be preferred. 
